Your browser doesn't support javascript.
loading
An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells.
Lee, Young Shin; Heo, Woong; Choi, Ho-Jung; Cho, Hae-Ryung; Nam, Ji Ho; Ki, Yong Gan; Lee, Hong-Rae; Son, Woo-Chang; Park, You-Soo; Kang, Chi-Dug; Bae, Jaeho.
Afiliação
  • Lee YS; Department of Biochemistry, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Heo W; Department of Molecular Cell Biology and Genetics, Plus Biomedical Science Education Center, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Choi HJ; Department of Biochemistry, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Cho HR; Department of Molecular Cell Biology and Genetics, Plus Biomedical Science Education Center, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Nam JH; Department of Biochemistry, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Ki YG; Department of Molecular Cell Biology and Genetics, Plus Biomedical Science Education Center, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Lee HR; Department of Biochemistry, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Son WC; Department of Molecular Cell Biology and Genetics, Plus Biomedical Science Education Center, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Park YS; Department of Radiation Oncology, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Kang CD; Department of Radiation Oncology, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Bae J; Department of Research Center, Dongnam Institute of Radiological and Medical Sciences, Busan, Republic of Korea.
PLoS One ; 16(4): e0248870, 2021.
Article em En | MEDLINE | ID: mdl-33793576
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Melanoma Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Melanoma Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos